| http://www.w3.org/ns/prov#value | - he IL-1 and IL-6 inhibiting agents will alsoallow to decrease or even avoid the use of steroids in at least some of the patients with SJIA.In conclusion, similarly to the autoinflammatory syndromes such as FMF, and NOMID, theabnormalities in the innate rather than adaptive immunity play a major role in thepathophysiology of SJIA. Based on this, the emerging consensus is that SJIA should be vieweda
|
